Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #47,951 to #48,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Cancer cost-effectiveness of therapy (3 revisions)
  2. Cancer guided imagery (3 revisions)
  3. Cancer of unknown primary origin electrocardiogram (3 revisions)
  4. Cancer of unknown primary origin other imaging findings (3 revisions)
  5. Cancer of unknown primary origin primary prevention (3 revisions)
  6. Cancer of unknown primary origin screening (3 revisions)
  7. Cancer overview (3 revisions)
  8. Cancer patient (3 revisions)
  9. Cancer social impact (3 revisions)
  10. Cancer staging (3 revisions)
  11. Cancer survivors (3 revisions)
  12. Candesartan and Hydrochlorothiazide (patient information) (3 revisions)
  13. Candida tropicalis (3 revisions)
  14. Aerosol-PFC (3 revisions)
  15. Agada (3 revisions)
  16. Agglutination (3 revisions)
  17. Aggrecan (3 revisions)
  18. Aggrenox (3 revisions)
  19. Agitoxin (3 revisions)
  20. Aglepristone (3 revisions)
  21. Agni casti fructus (3 revisions)
  22. Agomelatine (3 revisions)
  23. Agyrophobia (3 revisions)
  24. Air crescent sign (3 revisions)
  25. Air embolism MRI (3 revisions)
  26. Air embolism electrocardiogram (3 revisions)
  27. Air embolism epidemiology and demographics (3 revisions)
  28. Air embolism history and symptoms (3 revisions)
  29. Air embolism medical therapy (3 revisions)
  30. Air embolism other imaging findings (3 revisions)
  31. Air embolism physical examination (3 revisions)
  32. Air embolism risk factors (3 revisions)
  33. Airway obstruction historical perspective (3 revisions)
  34. Airway obstruction natural history, complications and prognosis (3 revisions)
  35. Airway resistance (3 revisions)
  36. Ajmalicine (3 revisions)
  37. Akuammine (3 revisions)
  38. Alagille Syndrome Diagnosis (3 revisions)
  39. Alagille syndrome MRI (3 revisions)
  40. Alagille syndrome other diagnostic studies (3 revisions)
  41. Alagille syndrome risk factors (3 revisions)
  42. Alanine aminopeptidase (3 revisions)
  43. Alar fascia (3 revisions)
  44. Alatrofloxacin (3 revisions)
  45. Albendazole adverse reactions (3 revisions)
  46. Albendazole clinical pharmacology (3 revisions)
  47. Albendazole description (3 revisions)
  48. Albendazole warnings and precautions (3 revisions)
  49. Albinism chest x ray (3 revisions)
  50. Albinism primary prevention (3 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)